✦ LIBER ✦

The treatment of advanced bladder cancer with sensitized pig lymphocytes

✍ Scribed by R. C. L. Feneley; H. Eckert; A. G. Riddell; M. O. Symes; C. R. Tribe

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 382 KB
Volume: 61
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800611018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recent changes in the treatment of patie

Recent changes in the treatment of patients with advanced laryngeal cancer

✍ Eric M. Genden; Alfio Ferlito; Alessandra Rinaldo; Carl E. Silver; Johannes J. F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract Since the original data from the Department of Veterans Affairs Laryngeal Cancer Study Group demonstrated that nonsurgical therapy could achieve survival rates comparable to total laryngectomy in selected cases, there has been a progressive increase in employment of nonsurgical therapy

Acute and late morbidity in the treatmen

Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide

✍ Peter J. Hoskin; Ana M. Rojas; Heather Phillips; Michele I. Saunders 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

Circadian rhythm modulated 5-FUdR infusi

Circadian rhythm modulated 5-FUdR infusion with megace in the treatment of advanced pancreatic cancer

✍ Robert de W. Marsh; Vani Manyam; Carol Bewsher; Margaret Youngblood 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

## Abstract Thirteen patients with advanced pancreatic carcinoma were treated with circadian rhythm modulated infusion of 5‐FUdR and Megace. Treatment was initiated at a dose of 0.15 mg/kg/day for 14 days every 28 days and was increased or decreased by 0.025 mg/kg/day with each subsequent cycle unt

Clinical evaluation of the treatment of

Clinical evaluation of the treatment of advanced head and neck cancers with high-energy electron beams

✍ Harold Perry; Florence C. H. Chu; Toshio Kitagawa; Arvin S. Glicksman; James J. 📂 Article 📅 1966 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB 👁 2 views

Local but no systemic immunomodulation b

Local but no systemic immunomodulation by intraperitoneal treatment of advanced ovarian cancer with autologous T lymphocytes re-targeted by a bi-specific monoclonal antibody

✍ Cor H.J. Lamers; Reinder L.H. Bolhuis; Sven O. Warnaar; Gerrit Stoter; Jan W. Gr 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 201 KB 👁 1 views

We have reported a 27% overall anti-tumor response using i.p. immunotherapy of advanced ovarian carcinoma with autologous, ex vivo expanded, T lymphocytes re-targeted with bi-specific monoclonal antibody OC/TR, combined with soluble OC/TR and low-dose recombinant interleukin-2 (IL-2). This treatment

Dose intensive combination platinum and

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer

✍ Jeremy D. Shapiro; Mace L. Rothenberg; Gisele A. Sarosy; Seth M. Steinberg; Debr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## BACKGROUND. The authors combined cisplatin and carboplatin together with cyclophosphamide to maximize platinum dose intensity in patients with advanced epithelial ovarian cancer (AOC). ## METHODS. The authors treated 26 consecutive, newly diagnosed patients with International Federation of G